A head to head comparison of nine tools predicting non‐sentinel lymph node status in sentinel node positive breast cancer women

Abstract

Current models for predicting non-SLN metastases in SLN positive breast cancer are not yet ready for implementation in general practice. Further research efforts should improve model performance in selecting patients or perhaps find a role in support in the paradigm shift to a "treat none unless" approach.